公開日期 | 標題 | 作者 | 來源出版物 | WOS | 全文 |
2010 | Phase I/II Trial of GN-BVC, a Gemcitabine and Vinorelbine-Containing Conditioning Regimen for Autologous Hematopoietic Cell Transplantation in Recurrent and Refractory Hodgkin Lymphoma | Arai, S.; Letsinger, R.; Wong, R. M.; Johnston, L. J.; Laport, G. G.; Lowsky, R.; Miklos, D. B.; Shizuru, J. A.; Wen-Kai Weng ; Lavori, P. W.; Blume, K. G.; Negrin, R. S.; Horning, S. J. | Biology of Blood and Marrow Transplantation | | |
2012 | Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidence | Arai, S.; Sahaf, B.; Narasimhan, B.; Chen, G. L.; Jones, C. D.; Lowsky, R.; Shizuru, J. A.; Johnston, L. J.; Laport, G. G.; Wen-Kai Weng ; Benjamin, J. E.; Schaenman, J.; Brown, J.; Ramirez, J.; Zehnder, J. L.; Negrin, R. S.; Miklos, D. B. | Blood | | |
2012 | Tandem chemo-mobilization followed by high-dose melphalan and carmustine with single autologous hematopoietic cell transplantation for multiple myeloma | Chen, A. I.; Negrin, R. S.; McMillan, A.; Shizuru, J. A.; Johnston, L. J.; Lowsky, R.; Miklos, D. B.; Arai, S.; Wen-Kai Weng ; Laport, G. G.; Stockerl-Goldstein, K. | Bone Marrow Transplantation | | |
2009 | TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors | Kohrt, H. E.; Turnbull, B. B.; Heydari, K.; Shizuru, J. A.; Laport, G. G.; Miklos, D. B.; Johnston, L. J.; Arai, S.; Wen-Kai Weng ; Hoppe, R. T.; Lavori, P. W.; Blume, K. G.; Negrin, R. S.; Strober, S.; Lowsky, R. | Blood | | |
2016 | Validation of the hematopoietic cell transplantation-specific comorbidity index in non-myeloablative allogeneic stem cell transplantation | Veeraputhiran, M.; Arai, S.; Lowsky, R.; Miklos, D. B.; Meyer, E.; Muffly, L. S.; Negrin, R.; Rezvani, A. R.; Shizuru, J.; Wen-Kai Weng ; Johnston, L. J. | Journal of Clinical Oncology | | |